Oregon 2017 Regular Session Status: In Committee 1 D cosponsors

SB 793 — Relating to the price of prescription drugs; declaring an emergency.

Last action — In committee upon adjournment.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2017 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Requires prescription drug manufacturer to report to Department of Consumer and Business Services prices and increases in prices of manufacturer's prescription drugs sold in Oregon. Requires manufacturer to provide justification for increase in price greater than 3.4 percent for prescription drugs sold in Oregon longer than 36 months. Requires department to order manufacturer to refund excessive price increases to purchasers of prescription drugs. Declares emergency, effective on passage.

Bill Text

We don't have the full text on file for this bill yet.

Read SB 793 on the official Oregon source →

Action History

  1. In committee upon adjournment.

  2. Work Session held.

  3. Public Hearing held.

  4. Referred to Health Care.

  5. Introduction and first reading. Referred to President's desk.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 0 co-sponsors · 88 not signed on

Sponsors (2)

Co-sponsors (0)

None.

Not signed on (88)

88 members have not signed on to this bill.

Show all 88 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 793 do?
Requires prescription drug manufacturer to report to Department of Consumer and Business Services prices and increases in prices of manufacturer's prescription drugs sold in Oregon. Requires manufacturer to provide justification for increase in price greater than 3.4 percent for prescription drugs sold in Oregon longer than 36 months. Requires department to order manufacturer to refund excessive price increases to purchasers of prescription drugs. Declares emergency, effective on passage.
Who sponsors SB 793?
SB 793 is sponsored by Rob Nosse (Democrat) and Elizabeth Steiner Hayward.
What is the current status of SB 793?
This bill died with 2017 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 793?
Track SB 793 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 793

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 793

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →